|
|
|
Insider
Information: |
Rummelt Andreas |
Relationship: |
Director |
City: |
Cheshire |
State: |
CT |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
1 |
|
Direct
Shares |
0 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$0 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
0 |
|
|
Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Alexion Pharmaceuticals Inc |
ALXN |
Director |
2021-07-21 |
0 |
2010-02-23 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
21 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
ALXN |
Alexion Pharmaceuticals I... |
Director |
|
2010-02-23 |
4 |
OE |
$48.72 |
$189,618 |
D/D |
3,892 |
3,892 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
Director |
|
2010-05-10 |
4 |
B |
$52.60 |
$263,000 |
D/D |
5,000 |
8,892 |
2.39 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
Director |
|
2010-11-23 |
4 |
OE |
$53.28 |
$105,654 |
D/D |
1,983 |
10,875 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
Director |
|
2011-02-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,725 |
13,600 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
Director |
|
2012-02-21 |
4 |
S |
$81.27 |
$226,418 |
D/D |
(2,786) |
30,315 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
Director |
|
2012-02-21 |
4 |
OE |
$49.43 |
$137,712 |
D/D |
2,786 |
33,101 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
Director |
|
2012-02-23 |
4 |
S |
$84.96 |
$310,699 |
D/D |
(3,657) |
30,315 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
Director |
|
2012-02-23 |
4 |
OE |
$24.36 |
$89,085 |
D/D |
3,657 |
33,972 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
Director |
|
2012-07-27 |
4 |
S |
$107.00 |
$1,070,000 |
D/D |
(10,000) |
10,315 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
Director |
|
2013-02-06 |
4 |
A |
$0.00 |
$0 |
D/D |
2,471 |
12,786 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
Director |
|
2014-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
895 |
13,181 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
Director |
|
2014-08-25 |
4 |
S |
$170.53 |
$861,518 |
D/D |
(5,052) |
12,786 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
Director |
|
2014-08-25 |
4 |
OE |
$24.36 |
$157,989 |
D/D |
5,052 |
17,838 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
Director |
|
2015-05-06 |
4 |
A |
$0.00 |
$0 |
D/D |
700 |
13,486 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
Director |
|
2016-05-11 |
4 |
A |
$0.00 |
$0 |
D/D |
835 |
15,216 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
Director |
|
2017-05-10 |
4 |
A |
$0.00 |
$0 |
D/D |
2,030 |
17,246 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
Director |
|
2018-05-09 |
4 |
A |
$0.00 |
$0 |
D/D |
2,174 |
19,420 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
Director |
|
2019-05-15 |
4 |
A |
$0.00 |
$0 |
D/D |
2,726 |
22,146 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
Director |
|
2020-05-14 |
4 |
A |
$0.00 |
$0 |
D/D |
3,468 |
25,614 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
Director |
|
2021-05-20 |
4 |
A |
$0.00 |
$0 |
D/D |
2,495 |
28,109 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
Director |
|
2021-07-21 |
4 |
D |
$0.00 |
$0 |
D/D |
(28,109) |
0 |
0 |
- |
|
21 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|